Abstract
The study was undertaken to evaluate the effectiveness of angiotensin II receptor antagonist eprosartan according to its effects on blood pressure (BP) and cognitive function in 56 patients with Stage I-II arterial hypertension (AH) associated with light and moderate cognitive disturbances. Six-month monotherapy with eprosartan resulted with multiple beneficial effects: target BP level achievement, circadian BP profile normalization and improvement of some cognitive function (perception, memory and concentration).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
